Abstract
Multiple sclerosis is an autoimmune disease that causes psychological impacts and severe physical disabilities, including motor disabilities and partial blindness. This work introduces an early detection method for multiple sclerosis disease by analyzing transcriptomic microRNA data. By transforming this phenotype classification problem into a text mining problem, multiple sclerosis disease biomarkers can be obtained. To our knowledge, text mining methods have not been introduced previously in transcriptomic data analysis of multiple sclerosis disease. Hence, this work presents a complete predictive model by combining consecutive transcriptomic data preprocessing procedures, followed by the proposed KmerFIDF method as a feature extraction method and linear discriminant analysis for dimensionality reduction. Predictive machine learning methods can then be obtained accordingly. This study describes experimental work on a transcriptomic dataset of noncoding microRNA sequences denoted from relapsing-remitting multiple sclerosis patients before fingolimod treatment and after six consecutive months of treatment. The experimental results of the predictive methods with the proposed model report sensitivity, specificity, F1-score, and average accuracy scores of 96.4, 96.47, 95.6, and 97% with random forest, 92.89, 92.78, 93.2, and 94% with support vector machine and 91.95, 92.2, 93.1, and 94% with logistic regression, respectively. These promising results support the introduced model and the proposed KmerFIDF method in transcriptomic data analysis. Moreover, comparative experiments are conducted with two referenced studies. The obtained results show that the average reported accuracy scores of the proposed model outperform the referenced literature work.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.